Shravan Kumar Gunda

According to our database, Shravan Kumar Gunda authored at least 4 papers between 2012 and 2017.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of six.

2017

3D-QSAR (CoMFA, CoMSIA) and molecular docking studies of natural flavonoid derivatives to explore structural requirements for MCF-7 cell line inhibition.

Shravan Kumar Gunda, Manasa Reddy Gummi, Jaheer Mohmed, Ayub Shaik

Int. J. Comput. Biol. Drug Des., 2017

2015

Natural flavonoid derivatives as oral human epidermoid carcinoma cell inhibitors.

Shravan Kumar Gunda, Sofia Florence Kongaleti, Mahmood Shaik

Int. J. Comput. Biol. Drug Des., 2015

2014

P56^lck kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.

Shravan Kumar Gunda, Sandeep Kumar Mulukala Narasimha, Mahmood Shaik

Int. J. Comput. Biol. Drug Des., 2014

2012

3D QSAR CoMFA/CoMSIA and docking studies on azole dione derivatives, as anti-cancer inhibitors.

Rohith Kumar Anugolu, Shravan Kumar Gunda, Mahmood Shaik

Int. J. Comput. Biol. Drug Des., 2012